Sleeping Pills Market 2018-2025 | By Top Key Players: Merck & Co. Inc., GlaxoSmithKline plc., CareFusion, Apotex Inc., Sanofi, Takeda Pharmaceutical Company Limited, Pfizer Inc, Eli Lilly and Company, Dr. Reddy’s Laboratories Ltd and More

Sleeping Pills Market

Sleeping Pills induces sleep, which could be an effective treatment for chronic insomnia. Sleeping drugs or pills are powerful hypnotic; hence, can cause a strong urge to sleep. Chronic insomnia could have a negative impact on an individual’s health such as increased risk of depression, high blood pressure, and could also lower the quality of life or lifestyle. Sleep deprivation could cause neural problems that could lower the productivity of work done by an individual and can cause hypertension, stress, and depression. Some of the common sleeping pills taken worldwide are Zaleplon, Eszopiclone, Benzodiazepines, Temazepam, and others.

A sample of this report is available upon request @ https://www.reportsmonitor.com/request_sample/3516

The study of NCBI stated that chronic insomnia was seen in 33% of the adult population that was being sampled. Rising age and diabetes were found to be significantly associated with insomnia disorder, 27% of patients who had insomnia did not perceive the condition, which was statistically significant.

Key Manufacturers of Global Sleeping Pills Market:
Merck & Co. Inc., GlaxoSmithKline plc., CareFusion, Apotex Inc., Sanofi, Takeda Pharmaceutical Company Limited, Pfizer Inc, Eli Lilly and Company, Dr. Reddy’s Laboratories Ltd and More

The factors that have a positive impact on the growth of the global sleeping drug market include growing per capita healthcare expenditure in developing economies, growing prevalence of insomnia, growing awareness programs regarding the importance of ample sleep, and rising demand for sleeping pills in modern and fast lifestyle.

However, due to the side-effects of sleeping drugs in today’s market, alternatives and conventional sleeping aids are more favorable, these include acupuncture, herbal or dietary medicine, homeopathy, and bodywork or yoga, and others. Sleeping pills are generally taken for a short period of time, ideally less than two weeks and are advised to be consumed intermittently. This may hamper the market growth in future.

Market Segmentation:
The global sleeping pills market is bifurcated on the following bases:
Product Type:
• Benzodiazepines
• Non Benzodiazepines

Use:
• Short-term Use
• Long-term Use

Melatonin Receptors:
• MT(1)
• MT(2)

Regions:
North America – US and Canada
Europe – UK, Germany, Italy, and France
APAC – China, Japan, and India
LAMEA – GCC Countries, Mexico, and Africa

Get Upto 50% Discount on this report @ https://www.reportsmonitor.com/check_discount/3516

Geographically, the global sleeping pills market is divided into North America, Europe, Asia Pacific, and Latin America, Middle East and Africa. North America is attributed to have the significant share in the market with countries like U.S and Canada, owing to rising count of insomniac individuals. It is attributed that 50 to 70 million Americans chronically suffer from a disorder of sleep, impeding daily functioning and badly affecting their health (PubMed). As per the report of American Academy of Sleep Medicine, nearly 30 to 35% of the U.S population has the symptoms of brief insomnia. Around 15 to 20% people of the total U.S population have a short-term insomnia disorder, and 10% are accounted to have a chronic insomnia disorder, which usually occurs at least three times weekly for at least three months. This increasing sleep disorders and the rising insomniac population can contribute to North America’s market growth.

Europe market is expected to share the same potential with the countries like Germany, France, U.K, Spain, Italy, and others. According to the study of a Men’sHealth magazine (U.K), over 12 million prescriptions for insomnia disorder was handed out to help people to get a full eight hours sleep.

Reasons for Buying this Report:
This research study provides a detailed analysis of the changing competitive dynamics.
It also provides a forward-looking view of the various components responsible for driving or constraining the growth of the market.
It provides a technological growth map over time, so as to comprehend the industry growth rate.
It likewise provides a five to seven-year forecast evaluated on the basis of how the industry is forecasted to grow.
It helps in comprehending the key product segments and their future growth prospects.

Avail complete report of this research @ https://www.reportsmonitor.com/report/3516/Sleeping-Pills-Market

Available Customization With the given market data, Reports Monitor offers customizations according to the company’s specific needs. The following customization options are available for the report:
The Regional and country-level analysis of the Sleeping Pills Market, by end-use.
The Detailed analysis and profiles of additional market players.

About Us:
Reports Monitor is a market intelligence and consulting firm with extensive experience and knowledge of the Market Research industry.

Our aim is to change the dynamics of the Market Research industry by providing quality intelligence backed by data. Your requirement for market forecasting is fulfilled by our exclusive quantitative and analytics-driven intelligence. Decision makers can now rely on our distinct data gathering methods to get factual market forecasting and detailed analysis.

Contact Us:
Jay Matthews
Direct: +1 513 549-591481 (U.S.), +44 203 318 2917 (U.K.)
Email: sales@reportsmonitor.com
Linkedin: https://www.linkedin.com/company/reports-monitor
Twitter: https://twitter.com/reportsmonitor

This release was published on openPR.